InvestorBrandNetwork (IBN) Content Platform

Starco Brands (OTCQB: STCB) today announced that Whipshots(TM), the groundbreaking vodka-infused whipped cream, has won awards in two prestigious spirit industry competitions. The whipped cream brand, developed in collaboration with global artist and icon Cardi B, received a “Rising Star Award” in Beverage Dynamics’ 2023 Growth Brands Awards as well as four medals in the 2023 DB & SB Spring Blind Tasting as part of the Global Spirits Masters Competition. “We’re ecstatic that Whipshots has been recognized by both the Growth Brands Awards and the DB & SB Spring Blind Tasting,” said David Dreyer, chief marketing officer of Starco Brands. “Receiving these honors is extremely rewarding and further showcases our product as a disruptor in the industry from a brand and taste standpoint.”

To view the full press release, visit https://ibn.fm/5aq5L

About Starco Brands Inc.

Starco Brands invents consumer products with behavior-changing technologies that spark excitement in the everyday. Today, its disruptive brands include: Whipshots, the world’s only vodka-infused whipped cream; Art of Sport, the body care brand designed for athletes and co-founded by Kobe Bryant; Winona Popcorn Spray, the first indulgent theater-popcorn spray powered by air; Skylar, the only fragrance that is both hypoallergenic and safe for sensitive skin; and Soylent, the complete non-dairy nutrition brand. A modern-day invention factory to its core, Starco Brands identifies whitespaces across consumer product categories. It draws upon a portfolio of innovative formulas spanning eight product categories with limitless innovation potential. Starco Brands publicly trades on the OTCQB stock exchange so that retail investors can invest in STCB alongside accredited individuals and institutions. Visit www.starcobrands.com for more information.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Friendable (OTC: FDBL), a mobile technology, marketing and software services provider, has acquired an additional intellectual property asset; the company has purchased the OnlyFanPass.com domain name. The transaction is part of the company’s focus on leveraging existing tech, streaming and digital platform assets for new markets in 2023. “Having developed such a wealth of technology assets over the previous years, it’s been very rewarding to have dug our heels in on what and how we may repurpose certain aspects or modules of what we developed for exciting new business opportunities that are showing rapid growth,” said Friendable CEO Robert A. Rositano Jr. in the press release. “We’ve also been able to analyze the marketplace, other products, technologies and opportunities we have as a company/business moving into 2023 and beyond. As we continued to focus on market opportunities and rapid paths to revenue, the OnlyFans business model was staring right at us. As we analyzed our technology, it was easy to see that we could meet and deploy for an OnlyFans market opportunity more rapidly than the TikTok competitive app and have begun to run a parallel effort to bring these both to the market. Having these new opportunities take shape without having to spend the time or development dollars of the past to achieve is one of the things I’m most excited about. Timing is everything and by leveraging monies and time spent, along with what we’ve learned along the way, we will have various new ways of pushing products and partners into existing markets and capture our collective share of revenue.”

To view the full press release, visit https://ibn.fm/K5X3Z

About Friendable Inc.

Friendable is a mobile technology, marketing and software services provider. The company has developed a base of technologies that have been productized beginning in 2013 and is now leveraging these various technologies to power certain Friendable-owned brands, as well as white-label offerings to companies or entrepreneurs seeking to enter an existing market quickly and cost effectively, leveraging the many years of technology developed and owned by the company. Friendable is also involved in the marketing, development and identification of products, services or brand opportunities the company feels have mass market potential and scalability. Friendable was founded by brothers Robert A. Rositano Jr. and Dean Rositano, who have more than 27 years of experience working together on technology-related ventures. For more information about the company, visit www.Friendable.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

NextPlat Corp. (NASDAQ: NXPL), a global e-commerce provider, has inked a merchant sourcing agreement with Alibaba Group Holding Limited to leverage NextPlat’s global capabilities and Alibaba’s global Tmall, enabling businesses to reach millions of potential new customers in China. Through the collaboration, the companies will focus on increasing the sales of products produced and sold by American companies and sold to the multitrillion-dollar Chinese consumer market. Based on the agreement, NextPlat and its customers, which are companies primarily based in and producing products in the United States and throughout the Americas, can use Alibaba’s Tmall Global e-commerce platform to sell products to Chinese consumers. NextPlat plans to officially launch the first in a series of new e-commerce development programs later today; the launch event, which will take place at the Hangar Coconut Grove in Miami, will feature a keynote address by Alibaba Group president Michael J. Evans.

The initial e-commerce development program will help Florida-based businesses and manufacturers market and sell their products to potentially millions of new customers with plans to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America as well as Central and South America. “We are excited to kick off a dynamic new e-commerce development program with Tmall here in South Florida and bring the opportunity of new business in China to more American-based companies,” said NextPlat Corp. executive chair and CEO Charles M. Fernandez in the press release. “Alibaba is one of the world’s preeminent e-commerce platform companies and the leader in serving the needs of millions of consumers and businesses throughout China and Asia. With our expanded relationship with Alibaba and Tmall, we are combining our collective expertise and capabilities to provide American businesses with a novel, turn-key international e-commerce solution that can provide them with access to potentially millions of new customers without having to invest in international operations and infrastructure.”

To view the full press release, visit https://ibn.fm/0VuMJ

About NextPlat Corp

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets. The company intends to collaborate with businesses, optimizing the ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications services division through its Global Telesat Communications Ltd. and Orbital Satcom Corp. business units, which offer voice, data, tracking and IoT services to customers worldwide through multiple global storefronts. For more information about the company, please visit www.NextPlat.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Starco Brands announced in March 2023 that Whipshots has sold over two million cans since its December 2021 launch
• The company announced in February 2023 its acquisition of Soylent Nutrition Inc., which pioneered the plant-based “complete nutrition” and “functional food” categories
• Soylent in March 2023 announced an expanded partnership with Meijer Grocery Stores, making its nutrition shakes available at hundreds of Meijer locations
• Starco Brands in January 2023 entered into a definitive agreement to acquire Skylar, a maker of hypoallergenic fragrances that are safe for sensitive skin

Starco Brands (OTCQB: STCB) is a modern-day invention factory. The company’s unwavering mission is to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday.

This consumer product company has grown from a couple million dollars in revenue to approximately…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to STCB are available in the company’s newsroom at https://ibn.fm/STCB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals and other industries, is making changes to its license offerings. The company announced a strategic decision to offer up to five exclusive licenses to its patented and powerful UltraShear Technology(TM) (UltraShear or UST) platform for the processing of oil-soluble THC concentrates in water into long-term stable, effectively water-soluble and highly bioavailable nanoemulsions. According to the announcement, PBI is offering a limited number of three-year, exclusive, statewide licenses to its patented UltraShear technology platform with processing equipment being custom manufactured for each licensee. The company noted that each exclusive license will be for a single state, with the licensee paying an up-front license fee plus the cost to build the custom equipment, which will be placed in their facility; that equipment will be offered with a no-cost, three-year lease. Licensees will have first rights to negotiate an extension of the license once the initial lease period is over. “The unsatisfactory long onset and full dosing delay associated with THC edibles, contrasted with the health concerns associated with smoking/vaping, continues to present a frustrating dilemma for users,” said Pressure BioSciences director of sales and marketing John Hollister in the press release. “PBIO Issues associated with effectively mixing THC with beverages have remained frustratingly unresolved to date. Over the past few months, we have generated a large amount evidence that our UltraShear platform definitively resolves both of these critical limitations — UltraShear is now poised to redefine the entire cannabis industry.”

To view the full press release, visit https://ibn.fm/z9iyZ

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical and agrochemical, as well as food and beverage manufacturing. The company’s products utilize both constant and alternating pressure. Its patented enabling technology platform — Pressure Cycling Technology (“PCT”) — utilizes alternating cycles of pressure to control biomolecular interactions, such as cell lysis and biomolecule extraction, safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter bioterrorism applications. PBIO has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing the company to enter the biopharma contract services and GMP manufacturing equipment sector. The company has also developed the scalable and high-efficiency pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Reunion Gold (TSX.V: RGD) (OTC: RGDFF) is reporting on additional drill results from its wholly owned Oko West Project in Guyana. According to the company, the results continue to confirm the grade and continuity of the Kairuni zone, and Reunion Gold continues to explore further zones along strike. Specifically, the report showed that holes D-213, D-234 and D-243 confirm the presence of higher-grade mineralized “shoots” within block 4, which have been identified from previous drill results. According to the report, these higher-grade shoots remain open at depth, below the extent of drilling completed to date. In addition, initial results from Scout RC geochemical program on the western portion of the Oko West Prospecting License revealed several targets for follow-up drilling, and progress is being made on advancing and derisking the project. The drill program, which is part of an approximately 30,000-meter drill plan, was initiated at the beginning of this year. “We are advancing our Oko West project along two tracks,” said Reunion Gold president and CEO Rick Howes in the press release. “The first is to advance the exploration programs outside of the Kairuni zone, aimed at outlining and discovering additional gold mineralization within our Prospecting License. On this front, I am very excited by the results from the initial Scout RC Geochem drill program that is defining new targets west of our Kairuni zone. The second track is continuing to advance the Kairuni zone along the path to development as quickly as possible. We are currently on schedule to announce our Maiden Resource Estimate by the middle of the year, to be followed by the commencement of a PEA with targeted completion by year-end 2023.”

To view the full press release, visit https://ibn.fm/cx1bW

About Reunion Gold Corporation

Reunion Gold Corporation is a leading gold explorer in the Guiana Shield, South America. In 2021 the company made an exciting new gold discovery at its Oko West project in Guyana, where to date it has outlined continuous gold mineralization at the Kairuni zone over 2,000 meters of strike and to a depth of 600 meters. The mineralization appears to be open-pit amenable with a strong grade profile. In addition to Kairuni, there are several additional priority exploration targets on the Oko West project area that the company is exploring. For more information about the company, please visit www.ReunionGold.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Augmedix (NASDAQ: AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, has executed a strategic financing agreement. The agreement, which will raise $12 million in new equity, is with HCA Healthcare Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, and Redmile Group LLC, a San Francisco-based institutional healthcare investor. According to the announcement, the new funds will allow Augmedix to achieve positive cash flow without additional financing. In addition to the financing agreement, Augmedix and HCA have announced a partnership; the two companies will work together to advance the development of AI-powered ambient documentation products for acute care clinicians, a process that will help streamline hospital workflows, improve the ease of documentation and provide healthcare providers with more time to spend with patients. The products are designed to instantly convert typical clinician-patient conversations into medical notes for easy review; those notes can be seamlessly transferred in real time to the Electronic Health Record (EHR). “HCA Healthcare is a leader in deploying healthcare technology to improve patient outcomes and support physicians and nurses, and as such, they represent an ideal partner for Augmedix to deliver our innovative products to the industry at scale,” said Augmedix CEO Manny Krakaris in the press release. “As we continue to enhance our product offerings to best satisfy the needs of patients, nurses and physicians, we look forward to helping HCA Healthcare transform clinical documentation in the acute-care setting.”

To view the full press releases, visit https://ibn.fm/qsiWa and https://ibn.fm/GNvpa

About Augmedix Inc.

Augmedix delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals and telemedicine practitioners. Augmedix is on a mission to help clinicians and patients form a human connection at the point of care with seamless technology. Augmedix’s proprietary Notebuilder Platform extracts relevant data from natural clinician-patient conversations and converts that data into medical notes in real time, which are seamlessly transferred to the EHR. The company’s platform uses Automatic Speech Recognition, Natural Language Processing including Large Language Models, and medical documentation specialists to generate accurate and timely medical notes. Leveraging this platform, Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of clinician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.

For more information about the company, please visit www.Augmedix.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, has announced a reverse stock split of its common stock. According to the announcement, the stock split will be effective Monday, April 24, 2023, and will be at a ratio of 1 postsplit share for every 20 presplit shares. POAI common stock will continue to be traded on the NASDAQ Capital Market under the symbol POAI. The stock split decision was approved at an April 19, 2023, reconvened special meeting of stockholders, where stockholders granted the company’s board of directors the discretion to effect a reverse stock split through an amendment to the company’s Certificate of Incorporation; the ratio was to be determined by the board but parameters were not less than 1-for-2 and not more than 1-for-25. The objective of the reverse stock split is to bring the company into compliance with the minimum bid price requirement and maintain POAI’s listing on the NASDAQ Capital Market. The company noted that the reverse stock split will affect all holders of Predictive Oncology’s common stock uniformly and will not alter any stockholder’s percentage interest in the company’s equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share. Any fractional share of a stockholder resulting from the reverse stock split will be rounded up to the nearest whole number of shares.

To view the full press release, visit https://ibn.fm/SK8Uz

About Predictive Oncology Inc.

As a science-driven company on the leading edge of oncology drug discovery, Predictive Oncology (NASDAQ: POAI) offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to advance molecules into medicine more confidently by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the world’s largest privately held biobank of over 150K tumor samples. Predictive Oncology’s solutions additionally include tumor models, biologics development, formulation design, a GMP facility, a CLIA laboratory and substantial scientific domain expertise.

For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Golden Matrix Group (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, announced that company CEO Brian Goodman will be hosting an upcoming webcast. The event is specifically for GMGI shareholders and investors and will begin at 4 p.m. EDT on April 25, 2023. According to the announcement, the presentation will include a corporate overview as well as business updates on the company’s B2C segments, RKings Competitions and MEXPLAY. Goodman will also discuss the company’s progress in completing the MeridianBet Group acquisition. Time on the agenda has also been set aside for questions and answers. A replay of the webcast will be available on the company’s webcast following the event.

To view the webcast, visit https://ibn.fm/fALiU

To view the full press release, visit https://ibn.fm/EiFqK

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is an established B2B and B2C gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses proprietary gaming platforms for its extensive list of clients, and RKings, its B2C division, operates a high-volume ecommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. The company’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law. For more information about the company, visit www.GoldenMatrix.com

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Friendable (OTC: FDBL), a mobile technology, marketing and software services provider, today announced its approval for “Current Information” as it has met all compliance requirements related to its application and has now been approved by OTC Markets Group, Inc. “As we entered 2023, we understood our main goal was to reduce costs, reposition the technology assets and leverage market opportunities without entering long, expensive development cycles, which can sometimes move a company beyond its window of opportunity,” said Robert A. Rositano Jr., Friendable CEO. “With cost cutting efforts having been completed, the company is excited about 2023 as there are trending opportunities in markets that our technology is already suited for, and we expect to exploit these opportunities with our tech. This said, it’s all about how to rapidly iterate, provide white-label opportunities or out-of-the-box models that can scale with the right partnerships and nurturing what worked for us in 2022, which was the FeaturedX artist marketplace.”

To view the full press release, visit https://ibn.fm/WMD55

About Friendable Inc.

Friendable is a mobile technology, marketing and software services provider. The company has developed a base of technologies that have been productized beginning in 2013 and is now leveraging these various technologies to power certain Friendable owned brands, as well as white-label offerings to companies or entrepreneurs seeking to enter an existing market quickly and cost effectively, leveraging the many years of technology developed and owned by the company. The company is also involved in the marketing, development and identification of products, services or brand opportunities the company feels have mass market potential and scalability. For more information, visit www.Friendable.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a special purpose acquisition company (“SPAC”) formed to effect one or more business combinations with an intent to focus on the financial technology sector. The FEXD management team has extensive experience in developing global fintech platforms and services. “The company’s mission is to create and grow a global financial ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. FEXD plans to achieve this by acquiring and merging with financial technology pioneers that have the potential to help establish its global fintech ecosystem and by continuing the development of proprietary technologies and applications to keep the company at the forefront of the cashless society market. Digital money is replacing physical cash… FEXD is developing mobile transaction platforms, applications and services that are helping to implement these changes,” a recent article reads. “The company plans to offer a diverse portfolio of products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe, and Latin America. Its growth strategy includes acquisition, innovation and market development.”

To view the full article, visit https://ibn.fm/LzuTg

About Fintech Ecosystem Development Corp.

Fintech Ecosystem Development is a special purpose acquisition company formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector. The company is sponsored by Revofast LLC and the management team led by CEO, president and founder Dr. Saiful Khandaker and a group of experienced business and technology innovators. For more information about the company, please visit www.FintechEcosys.com.

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

EF Hutton, a premiere financial company that offers global customized solutions for public and private investment banking, is proud to announce the inaugural EF Hutton Global Conference to be held on May 10-11, 2023, at The Plaza Hotel in New York City. This event will showcase dynamic private and public companies across various sectors, bringing individuals in these spaces together to interact, exchange ideas and discuss ways to take their organizations to the next level.

The two-day invitation-only event will feature approximately 150 public and private companies, with attendees enjoying a unique one-on-one format intended explicitly for engagement, interaction, healthy discussions, and next-level networking. The conference will not feature any general presentations, with…

Read More>>

To learn more, please visit https://efhconference.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

In today’s fast-paced world, effective communication is more important than ever to the success of any company. The right communication solutions are imperative to connect with target markets, improve customer satisfaction and increase corporate productivity. There are a myriad of communication solutions available, but there’s only one that stands out as the most innovative and effective.

IBN is the recognized leader in providing communication solutions for businesses of all sizes. IBN provides a wide range of services that fit the needs of companies large and small – services that cut…

Read More>>

For more information, visit www.InvestorBrandNetwork.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and post-traumatic stress disorder, has closed on its previously announced Common Share Subscription Agreement. According to the announcement, the agreement is with a third-party investor. The original agreement was dated March 10, 2023, with the company filing a shelf prospectus supplement regarding the agreement on April 4, 2023. The closing was on the second issuance under the offering, which resulted in 2,061,855 common shares in the capital of the company being issued. The shares were issued at $0.485 per share with the company seeing gross proceeds of $999,999.68; the company outlined how it anticipates using the shares in the previously filed prospectus supplement.

To view the full press release, visit https://ibn.fm/yWoBO

About Mydecine Innovations Group Inc.

Mydecine Innovations is a biotechnology company developing the next generation of innovative medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (“PTSD”). The core strategy blends advanced technology with an elaborate infrastructure for drug discovery and development. Mydecine’s dedicated multinational team constantly develops new paths for breakthrough treatment solutions in areas with considerable unmet needs. By collaborating with some of the world’s leading specialists, the company aspires to responsibly speed up the development of breakthrough medications to provide patients with safer and more-effective treatment solutions. At the same time, Mydecine’s approach focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with world-class scientific and regulatory expertise. Based out of Colorado, Mydecine was founded in 2020, and has offices in Canada and the Netherlands.

NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the only provider building both annealing and gate-model quantum computers, has published a peer-reviewed milestone paper showing the performance of its 5,000 qubit Advantage(TM) quantum computer is significantly faster than classical compute on an intractable class of optimization problems – 3D spin glasses. The paper also represents the largest programmable quantum simulation reported to date. A collaboration between scientists from D-Wave and Boston University, the paper titled “Quantum critical dynamics in a 5,000-qubit programmable spin glass,” was published in the peer-reviewed journal Nature today and is available here.

“This research marks a significant achievement for quantum technology, as it demonstrates a computational advantage over classical approaches for an intractable class of optimization problems,” said Dr. Alan Baratz, CEO of D-Wave. “For those seeking evidence of quantum annealing’s unrivaled performance, this work offers definitive proof.”

To view the full press release, visit https://ibn.fm/dhs9r

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services Global (OTCQB: SHRG) and DSS Inc. (NYSE American: DSS) have announced plans to distribute to stockholders SHRG common stock that is beneficially held by DSS. The distribution will be done through DSS subsidiary, Decentralized Sharing Systems Inc. (“DSSI”). Sharing Services is a diversified direct marketing company that is in the process of uplisting to NASDAQ; DSS is a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs. A major shareholder in Sharing Services, DSS is identifying opportunities that will support long-term growth for SHRG as well as provide long-term benefit to its shareholders. According to the announcement, DSS plans to distribute approximately 280 million shares, valued at more than $5 million at the current market value, in a distribution to holders of DSS common stock. “We look forward to having DSS shareholders as part of our shareholder base through the direct distribution of SHRG shares,” said Sharing Services Global CEO John “JT” Thatch in the press release. “We also are excited to grow the relationship with DSS and see great potential with them as we expand our distribution network and global footprint to create additional revenue and growth.”

To view the full press release, visit https://ibn.fm/MfD5w

About Sharing Services Global Corporation

Sharing Services Global Corporation is a publicly traded company dedicated to building shareholder value by developing or acquiring businesses, products and technologies in the direct-selling industry and other industries that augment the company’s product and services portfolio, business competencies, and geographic reach. The company’s primary growth strategy is built on focused innovation and creativity positioned to capture profitable market share of diverse business models. For more information, please visit the company’s website at www.shrginc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that its research collaborators presented positive preclinical data for the NPRL2 gene (also known as the TUSC4 gene). According to the announcement, the studies used the company’s non-viral ONCOPREX(R) Nanoparticle Delivery System in KRAS/STK11 mutant anti-PD1 resistant metastatic human non-small cell lung cancer (“NSCLC”) humanized mouse models. The results were presented at the 2023 American Association of Cancer Research (“AACR”) annual meeting, which took place from April 14-18, 2023, in Orlando, Florida. “We are pleased to have these positive data that support the therapeutic potential of our non-viral delivery system, which is being used in our current REQORSA(R) clinical oncology programs, presented before some of the world’s leading cancer researchers,” said Rodney Varner, president and chief executive officer at Genprex. “The use of the ONCOPREX Nanoparticle Delivery System to deliver the NPRL2 tumor suppressor gene positions Genprex to expand our clinical pipeline with a new drug candidate. The preclinical data also provide further evidence that the ONCOPREX Nanoparticle Delivery System has the ability to be successful using genes other than the TUSC2 gene that we are already using in clinical trials with REQORSA.”

To view the full press release, visit https://ibn.fm/RScpe

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. The company’s lead product candidate, REQORSA(R) (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (“NSCLC”) and small cell lung cancer (“SCLC”). Both NSCLC clinical programs received a Fast Track Designation from the Food and Drug Administration. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an adeno-associated virus (“AAV”) vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of type 1 diabetes, GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In a similar approach, GPX-003 for type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has begun development of a novel formulation as a targeted prophylactic treatment. The company is developing the drug formulation in accordance with its sponsored research agreement with Columbia University. Designated as SPC-15, the treatment will be designed for stress, anxiety and PTSD. Stress-related disorders such as these are becoming more prevalent, with the World Health Organization reporting more than 300 million people struggle with an anxiety disorder. Fortune Business Insights is projecting that the global treatment market size for anxiety disorders and depression will reach $13 billion by 2027. Silo Pharma has a U.S. patent covering SPC-15 as a method for the treatment and prevention of stress-induced affective disorders in females, and studies indicate that SPC-15 exhibits promise as a potential therapeutic target for the treatment of cognitive impairment, PTSD and stress-related disorders. “We are advancing our development of SPC-15 through this formulation and feasibility study investigating dose strengths and delivery,” said Silo Pharma CEO Eric Weisblum in the press release. “The SPC-15 treatment protocol predicts levels of severity or progression of stress-related disorders and their metabolomic biomarkers’ response to pharmacological treatments. Based on our own research to date coupled with published preclinical data, we believe SPC-15 could have a profound impact on treating stress and anxiety disorders including PTSD, we will further use this data to help us with our upcoming studies related to SPC-14 Alzheimer’s asset.”

To view the full press release, visit https://ibn.fm/xgbQJ

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research indications for people suffering from indications such as Alzheimer’s disease, PTSD and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research that the company believes will be transformative to the well-being of patients and the healthcare industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH), a company founded with the belief that all companies deserve top-tier security guidance at a manageable cost, has a team of expert virtual Chief Information Security Officers (“vCISOs”) and virtual Chief Privacy Officers (“vCPOs”) who help companies build resilient cybersecurity and privacy programs, respectively. “Leveraging years of actual enterprise experience, SideChannel’s vCISOs provide clients with risk assessments that ensure cybersecurity compliance and help them develop a strategic vision, allocate resources and create protocols to maintain an effective cybersecurity program,” a recent article explains. “It is common knowledge that addressing cyber risk is increasingly challenging for companies and their boards, as the threat environment becomes more complex. SideChannel is providing access to expertise through experienced vCISOs, a dependable and consistent source of critical information and experience, enabling companies and boards to understand the cyber environment, develop and track the progress of cybersecurity programs, and embed elements of cyber risk mitigation into all of their strategic decisions and plans. When it comes to cybersecurity, a few steps now can prevent a world of regret later.”

To view the full article, visit https://ibn.fm/uBaLL

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite-level information security officers possesses a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora Growth (NASDAQ: FLGC), a leading cultivator, manufacturer and distributor of global cannabis products and brands, has appointed Hussein Rakine as CEO and a member of the board; the company also announced that Luis Merchan, board chair and CEO, had resigned both positions. Founder and CEO of Just Brands LLC, Rakine brings impressive experience to his new roles. Just Brands was acquired by Flora Growth in February 2022, and Rakine’s contributions have been vital to the company’s growth and success since then. Rakine is a serial entrepreneur who, in 2022, was named in Forbes’ 2022 30 Under 30 list. “I am enthusiastic about collaborating with our board of directors, executive team and all stakeholders to bring Flora’s business plan to fruition,” said Flora Growth CEO and board member Hussein Rakine in the press release. “In a nascent industry such as ours, it’s critical to stay nimble — and that is what I intend to do as I lead Flora into the next phase of growth. I would like to express our sincere appreciation to Luis for his unwavering commitment and dedication to the company during his tenure. We wish him all the best in his future endeavors. . . . We would like to address the current state of the market and emphasize our commitment to long-term success in the industry. With the global policies set to reignite the market, we are confident that there is significant potential for growth in the broader market. We acknowledge that we are still in the early stages of this industry, and we see significant upside potential moving forward. We remain optimistic about the future of this sector and look forward to playing a leading role in its continued growth and success.”

To view the full press release, visit https://ibn.fm/LB6fY

About Flora Growth Corp.

Flora Growth Corp. is a global cannabis company dedicated to bringing the benefits of cannabis to people worldwide. Our commitment is to create, master and connect the international cannabis supply chain by setting the standard for world-class cultivation and manufacturing, thoughtful brand development, and rigorous research and development of medical-grade cannabis products that meet the highest standards of quality, safety, and efficacy. Flora Growth’s mission is to create a world where the benefits of cannabis are accessible to everyone, and the company is working toward that goal by becoming a leading importer and exporter of cannabis to meet demand in every corner of the market. For more information about the company, please visit www www.FloraGrowth.com

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences field, and Artisan Industries, a worldwide leader in providing purification and separation technologies for the process industries, announced a strategic agreement between the companies. Under the agreement, PBIO will rent space and ancillary support in Artisan’s state-of-the-art facilities, dramatically increasing PBIO’s manufacturing capacity for servicing the needs of its growing portfolio of UltraShear Technology(TM) (“UltraShear(TM)” or “UST(TM)”)-based nanoemulsion clients. In addition, the relationship is expected to facilitate discussions between the companies towards an agreement that would secure Artisan as the exclusive manufacturer of PBIO’s revolutionary UltraShear equipment (the “BaroShear(TM)” line of products). “We are excited to have reached an agreement on a leap forward in our manufacturing capacity, capabilities and strategy that allows us to quickly transition from small, pilot scale lots for test markets (limitation of our current facilities) into large-scale servicing of UltraShear toll manufacturing contracts,” said Richard T. Schumacher, president and CEO of PBIO. “We expect that this transition will be completed over the next 30 days. We will also be actively exploring the potential for this relationship to produce an equipment manufacturing partnership, one that can accelerate our execution in scaling large UltraShear partners into our lease-and-license business model for their in-house manufacturing capacity, beginning in 2024.”

To view the full press release, visit https://ibn.fm/MTAy9

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) patented technology from BaroFold Inc. (the BaroFold technology) that allows entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based UltraShear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• An estimated 30,000 website data breaches occur each day on average
• Hacker targets include everyone online, ranging from small businesses to large and complex government agencies
• Massachusetts-based SideChannel Inc. delivers the services of chief information security officers (“CISOs”) on a contract basis to companies that don’t have budget capacity to maintain CISOs on staff full-time but desire protection against cyber threats
• SideChannel’s virtual CISOs work alongside company board officers to assess and strategically target operational risks
• SideChannel announced a strategic partnership last month with automated supply chain risk management platform developer Darkbeam that will strengthen SideChannel’s service offering

Cyber threats have become a standard concern for businesses working to maintain their operational integrity, with hackers accounting for an estimated 30,000 websites that are compromised on average each day. Techjury reported that the entire cost of cyberattacks in 2022 was $6 trillion and that the figure is expected to rise to $10.5 trillion by 2025 (https://ibn.fm/TjyS7).

The recent leak of timely international intelligence-related documents classified as not available for public review by the U.S. government’s information-gathering agencies has demonstrated that even government experts in the field are vulnerable to the possibility of data breaches and costly consequences resulting…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

The Alkaline Water Company (NASDAQ: WTER), the nation’s leading independent alkaline water company and the Clean Beverage(R) company, has announced that it added Alkaline88(R) products to over 11,000 new stores across the country during its fiscal year 2023, which ended March 31. In addition, the company added new SKUs in over 33,000 existing client locations in the past twelve months. “By expanding our presence in over 11,000 new stores and enhancing our offerings in more than 33,000 existing locations, we have demonstrated the resilience and adaptability of our company and the increasing strength of the Alkaline88 brand,” said Frank Chessman, president and CEO of The Alkaline Water Company. “Our brand’s expansion over the past year includes everything from local convenience stores to new distribution partnerships to major national retailers with thousands of locations across the country.”

To view the full press release, visit https://ibn.fm/qDnOv

About The Alkaline Water Company

The Alkaline Water Company is the Clean Beverage(R) company making a difference in the water you drink and the world we share. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for Alkaline88. To purchase The Alkaline Water Company’s products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that unaffiliated, independent researchers recently presented preclinical data on the tumor suppressor gene, TUSC2, reporting that it functions as a novel tumor suppressor for glioblastoma. TUSC2 is the suppressor gene that is re-expressed in tumors using Genprex’s lead drug candidate, REQORSA(R) Therapy treatment. “This research supports the growing body of studies evaluating TUSC2 as a target in oncology, and potentially an effective treatment for many types of cancer,” said Rodney Varner, chairman, president and chief executive officer of Genprex. “We are encouraged by the increasing number of research institutions and independent researchers producing positive data on TUSC2, which provide additional support for REQORSA(R) and its therapeutic potential against cancers.”

To view the full press release, visit https://ibn.fm/BaWPX

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. The company’s lead product candidate, REQORSA(R) (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (“NSCLC”) and small cell lung cancer (“SCLC”). Both NSCLC clinical programs received a Fast Track Designation from the Food and Drug Administration. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an adeno-associated virus (“AAV”) vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of type 1 diabetes, GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In a similar approach, GPX-003 for type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

IBN, a multifaceted financial news and publishing company for private and public entities, today announced the launch of Web3MediaWire as part of its continued commitment to communications solutions that deliver both targeted distribution and mass exposure. The launch of Web3MediaWire, a specialized communications platform focused on the next generation of internet technologies, is IBN’s latest foray into the “next big thing.” The platform covers companies and events spotlighting unique opportunities and the huge potential of Web3 to improve data security, enhance scalability and increase engagement among diverse audiences. As Web3 continues to evolve, Web3MediaWire is the place to keep pace with the latest trends and the next big names in the industry. IBN’s latest brand will be key in enhancing CryptoCurrencyWire’s existing collaborations with some of the biggest events in Web3, such as The Futurist Blockchain Conference, European Blockchain Convention, Outer Edge LA, Paris Blockchain Week Summit, Quantum Miami and Web3Toronto / DX3 Events. The collaborations put readers in the front row for the latest news, information and developments in the space.

To view the full press release, visit https://ibn.fm/PIKHU

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (“DBP”), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

ARway.ai (CSE: ARWY) (OTC: ARWYF) (FSE: E65), an AI-powered augmented reality experience platform with a disruptive no-code, no-beacon spatial computing solution enabled by visual marker tracking with centimeter precision, has announced that its exclusive spatial computing technology was chosen with Snap and Magic Leap at the 2023 Harvard XR Hackathon. The prestigious hackathon, called the Dream/Hack, was held April 14–16, 2023, by the Harvard Robotics Club and the Harvard AR/VR Club. The event, which was held at the Harvard John A. Paulson School of Engineering & Applied Sciences, featured creators, business leaders, domain experts, designers, developers, product managers and more. The event was designed for participants who had no previous AR/VR experience to explore business opportunities in the metaverse; ARway’s tech was an ideal solution for the event.  ARway provided training for those participating in the event, and users provided positive feedback as they worked on developing cutting-edge XR solutions to tackle complex global issues, ranging from education to climate change. In addition, the company announced that CEO Evan Gappelberg will be featured on a Proactive Investors Livestream event, slated for April 19, 2023; during the event, Gappelberg will discuss ARway.ai updates and answer questions. In addition, chief product officer Shadnam Khan will provide an ARway demo and presentation.

To view the livestream event, visit https://ibn.fm/WSsTg

To view the full press release, visit https://ibn.fm/WDm1j

About ARway.ai

ARway is an AI-powered platform that provides augmented reality experiences for indoor spaces. The platform allows users to easily create experiences for navigation, tours, information sharing, notifications, advertising, and gamification. ARway leverages the power of mobile devices to create environments that can improve visitor experience, boost employee productivity, increase engagement, create new advertising space, and boost revenues. Visitors can scan a QR code to access a venue map, navigate to any point of interest with step-by-step directions, learn information about those POIs, and interact with rich AR content and experiences along the way. ARway has unlimited use cases for augmenting physical spaces in the metaverse, making it a valuable tool for creators, brands, and companies in various industries. The complete ARway platform includes: the Web Creator Studio, the ARwayKit Software Development Kit (SDK) and a mobile app for iOs and Android.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Save Foods (NASDAQ: SVFD), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety, has sent a letter to stockholders from CEO David Palach. In the letter, Palach notes that SVFD is partnering with Plantify Foods Inc. (TSX.V: PTFY) in “a significant milestone for us [that] underscores our commitment to providing innovative and sustainable food solutions to customers around the world.” The letter outlines the partnership transaction, which included Save Foods issuing 1,164,374 shares of its common stock in exchange for the receipt of 30,004,349 shares of Plantify. In addition, the two companies executed an 18-month convertible debenture, with Save Foods extending a C$1,500,000 loan to Plantify, with an interest rate of 8% annually. Palach has talked previously about looking for collaborative opportunities. “I believe that Plantify is the perfect match for us,” said Save Foods CEO David Palach in the shareholder letter. “Plantify has already established direct relationships and sales channels with retailers globally, including KAYCO, a leading kosher food distributor in North America under Heaven & Earth brand, which presents a tremendous opportunity for Save Foods. Through this partnership, we will be able to offer our premium treatments, designed specifically for fresh cuts and berries, to Plantify’s products, reaching a wider customer base and expanding our sales opportunities. Additionally, Plantify is in the process of finalizing an agreement with another leading distributor of kosher food, which, if executed, may open up even more avenues for growth and distribution for both companies. Moreover, we are combining our marketing efforts to create a more impactful and efficient approach in the retail industry.”

To view the full press release, visit https://ibn.fm/LFoAN  

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agrifood tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and consumers alike. SVFD’s initial applications are in post-harvest treatments in fruit and vegetable packing houses that process produce such as citrus, avocado, pears, apples and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods treatments not only prolong fresh produce shelf life and reduce food loss and waste, but they also ensure a safe, natural, and healthy product. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced an additional contract win of $483,788 from one of the “Big Four” U.S.-based banks and largest fintech companies. According to the update, the client has expanded its usage of Data443’s leading secure file transport platform for the core of its intra-bank and governmental federal reserve data interchanges. Data443’s Data Placement Manager continues to deliver high-performance, secure and stable services for its thousands of partner banks, brokerage houses and multi-national government clients. “We are happy that Gartner includes ransomware recovery as a major capability requirement for data immutable data storage,” said Jason Remillard, CEO and Data443 founder, referring to a Gartner* report that discusses the common occurrence of ransomware attacks. “Our unique capabilities in restoring data and devices are a major differentiator for us and when it’s matched with our MFT [managed file transfer] capabilities – it really checks many boxes for our customers. This most recent deal is pure organic growth with another longtime customer and is indicative of where we think the market is going – new requirements, tough and complex operating environments and proven runtime are key to winning in this small segment of the data security marketplace.”

To view the full press release, visit https://ibn.fm/ZC14a

About Data443 Risk Mitigation Inc.

Data443 Risk Mitigation provides software and services to enable secure data across devices and databases, at rest and in flight/in transit, locally, on a network or in the cloud. The company is All Things Data Security(TM). With over 10,000 customers in over 100 countries, Data443 provides a modern approach to data governance and security by identifying and protecting all sensitive data regardless of location, platform or format. Its framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies. To learn more about Data443, watch the company’s video introduction on its YouTube channel: https://youtu.be/1Fp93jOxFSg

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

*Gartner, “Innovation Insight for Leveraging Isolated Recovery Environments and Immutable Data Vaults to Protect and Recover From Ransomware” Jerry Rozeman | Michael Hoeck, Sept. 28, 2022.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

AtomBeam, whose compaction product massively drives efficiency in data transmission and storage, has raised $1.3 million in its current crowdfunding campaign on StartEngine. Calling the milestone a “significant achievement,” the company noted its growing investor community in its efforts, saying that they “recognize the potential of AtomBeam’s technology to revolutionize how virtually every machine talks to another machine.” The company’s compaction technology is designed to disrupt how connected machines and the Internet of Things communicate, reducing the amount of data needing to be transmitted by an average of 75% and offering significant cost and efficiency benefits to both businesses and consumers. “This successful raise brings us one step closer to achieving our engineering goals and driving adoption of our technology,” said AtomBeam CEO Charles Yeomans in the press release. “Imagine your phone could send and receive data four times faster just with a software upgrade. Compaction does that by squeezing out all the inefficiencies in data transmission, and it does it so fast all you experience is, ‘Wow!’”

To view the full press release, visit https://ibn.fm/1lqwl

About AtomBeam Technologies Inc.

AtomBeam Technologies is a leading data-compaction company, and its technology reduces the amount of data that needs to be transmitted by an average of 75%, offering significant cost and efficiency benefits to businesses and consumers. For more information about the company, please visit www.AtomBeamTech.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, is expanding. The company announced that it has unveiled its new 4G GPS SmartSole in Denmark through its long-term distribution partner Safecall Aps. MetAlert’s technology promotes lifestyle wellness and independence for patients with mild cognitive impairment (“MCI”) who are more likely to require assistance from caregivers. Safecall Aps provides healthcare services and is one of the market leaders in providing GPS telehealth products to seniors in the private and government healthcare sectors throughout Denmark and Norway. “We are excited to be sending the first shipments of the new generation of 4G GPS SmartSole to support the healthcare sector in Denmark and Norway,” said MetAlert director Andrew Duncan in the press release. “Our distribution partner Safecall supplies all of the leading Alzheimer and Dementia treatment centers and clinics in this part of Europe. The Scandinavian countries are some of the most advanced countries in the world in the use of GPS tracking and remote patient monitoring technology for patients with MCI, consequently making it a large and important market for us. With our manufacturing ramping back up we are starting to fill our backorders and get back to normal delivery cycles.”

To view the full press release, visit https://ibn.fm/AOVyf

About MetAlert Inc.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling and licensing products, services and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With more than 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with movement, cognitive and spatial awareness disorders. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low-power consumption GPS, cellular, RF, NFC and BLE technologies, enabling caregivers to track and monitor patients in real time. The company is known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in more than 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information about this company, please visit www.MetAlert.com

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F), a clean technology company developing transformative power conversion technologies and control system solutions for electrical systems, today announced successful completion of the first milestone with a global tier one automotive leader in mobility innovation. Under the terms of the memorandum of understanding (“MOU”), announced on Oct. 20, 2022 , Hillcrest and the supplier are collaborating on the integration of an optimized version of Hillcrest’s ZVS-enabled, 250-kilowatt (kW), 800-Volt (V) Silicon Carbide (“SiC”) inverter into an electrical powertrain system. Hillcrest delivered the first demonstration test results, satisfying the first milestone of the MOU, and a purchase order has been issued for the next two milestones. “Completion of this milestone provides yet another validation of the capabilities of our proprietary ZVS technology,” said Hillcrest CTO Ari Berger. “I’m extremely proud of the team and the results we’ve achieved and excited to move forward to the next phase of activities with the global tier one supplier.”

To view the full press release, visit https://ibn.fm/Z80Sm

About Hillcrest Energy Technologies Ltd.

Hillcrest is a clean technology company developing high-value, high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. Hillcrest is publicly traded on the CSE under the symbol HEAT, on the OTCQB Venture Market as HLRTF and on the Frankfurt Exchange as 7HIA.F. For more information, please visit www.HillcrestEnergy.tech.

NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• As a lidar developer engaged with all Top 10 global automotive OEMs, Cepton is established in the automotive space; but as a technology that allows examination of natural and manmade environments with accuracy and precision, lidar can offer much more
• In addition to its work with leading automotive OEMs, Cepton has been also committed to forging partnerships beyond the automotive sector to improve infrastructure efficiency and safety around the world
• Cepton’s low-cost, high-resolution perception devices that enable scanning of environments have been deployed in projects around the world to transform spaces into smart infrastructure

Often coined as one of the most useful and versatile technologies of our time, lidar use cases go beyond merely enabling driver assistance functions in vehicles – although this is the application the technology is widely known for. As an optical technology that uses infrared light to measure distances, localize objects, or create maps of various areas with accuracy and precision, it can be used in practically any industry, from autonomous driving and logistics to robotics, construction, security, and agriculture, enhancing safety and productivity across a variety of end markets. As a provider of smart 3D-sensing lidar solutions, Cepton (NASDAQ: CPTN) has been collaborating with a number of global partners over the years to bring unique and accurate 3D imaging capabilities of this powerful technology beyond automotive applications to transform spaces into intelligent infrastructure.

Some of the collaborative projects include high-fidelity mapping and smart analytics on the fly for applications such as 3D modeling for building information modeling, historical site mapping, terrain modeling, volumetric mining calculations, power line inspection and forestry mapping…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, has adjourned its Special Meeting of stockholders. The company held the meeting on April 17, 2023, at 3 p.m., and then adjourned without any business being conducted. The company cited “lack of the required quorum” as the reason for the adjournment. According to the announcement, the Special Meeting was adjourned to allow additional time for company stockholders to vote on the proposal to effect a reverse stock split of the outstanding shares of its common stock at a ratio of not less than one-for-two and not more than one-for-twenty-five; the exact ratio will be determined by POAI’s board of directors. The Special Meeting has been scheduled for April 19, 2023, at 3 p.m. Only stockholders of record as of the record date, which was March 28, 2023, are entitled to vote at the Special Meeting.

To view the full press release, visit https://ibn.fm/hKBc2

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Together with the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based drug-discovery solutions, further complimented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, is setting up key partnerships with universities to provide upskilling and reskilling courses to their students. The company recently expanded its alliance with the National Association for Equal Opportunity in Higher Education (“NAFEO”), the college membership organization for all Historically Black Colleges and Universities (“HBCUs”) and Predominantly Black Institutions (“PBIs”), to include another 12 colleges and universities. The collaboration will enable NAFEO’s Center for Opportunity, Excellence and Equity (“COEE”), which provides economic mobility support to its members, to deliver its content through a learning management system powered by Amesite’s state-of-the-art platform. Amesite has been rapidly incorporating new technology into its platform and, with integration of generative AI capability, is assisting universities scale their professional education offerings, using technology to serve users any time of the day or night. “We are very pleased with the new entrants to the alliance and are thrilled to increase the potential impact we can have,” said Amesite CEO Dr. Anne-Marie Sastry. “With the integration of generative AI technology to complement our own tools, we are enabling our customers to deliver at scale, since learners on the platform can have questions answered, get help with content generation and view fresh content, 24/7.”

To view the full press release, visit https://ibn.fm/z8Awv

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics, and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Body camera analytics company Truleo today announced that its StartEngine raise has just reached $500,000. As the No. 1 provider of automated body camera reviews, Truleo believes that professional police behavior leads to more positive outcomes and that civilians are more willing to comply with the police when there is mutual respect. Truleo’s A.I. technology works by leveraging natural language processing to analyze the audio on an officer’s body camera and determine when conflict-based events may have occurred during a call for service. The officer’s language is then scored as professional or unprofessional. The company is tapping into a massive $10 billion market targeting 18,000 departments in the United States. Departments nationwide have benefited from Truleo’s body camera analytics, and its customers have reported experiencing a 36% decrease in use-of-force occurrences.

To view the full press release, visit https://ibn.fm/Ik1lE

About Truleo

Truleo has created a cutting-edge body camera analytics platform. The company’s revolutionary technology automatically processes 100% of BWC data and produces timely, actionable reports. For those interested in Truleo and its crowdfunding raise, visit the company’s page on StartEngine to learn more.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork